The Swiss hearing aid manufacturer Sonova has announced its results from the skewed financial year 2021/2022, surpassing expectations in several key areas, it reports in its financial results from the period on Monday.
A favorable basis for comparison secured a significant advance in figures compared to the same period last year, as the first half of 2021/2022 was characterized by a recovery of market conditions for hearing aids prior to the Covid-19 pandemic, though some challenges still remain.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.